The Shared Investigator Platform (SIP) is the success story of TransCelerate BioPharma’s collaborative vision brought to reality through a digital platform. SIP is delivering tangible, measurable benefits to sponsors and sites as more and more studies are onboarded and user adoption accelerates exponentially.
Beginning in February 2019, SIP will be available to sponsors outside of TransCelerate membership, as well as directly to CROs. The SIP User Forum is open to anyone whose organization is a current user of the platform or considering its adoption, including technology partners. Investigators and site personnel, who are able to join SIP at any time at no charge, are encouraged to attend.
- Understand the plan for SIP to transition from TransCelerate’s incubation to become a Cognizant product in 2020
- Hear from current SIP adopters on the benefits being realized
- See the new features of Version 3.1 and the product roadmap of future releases
- Provide your input on current and future features and functions of SIP
Trifecata is a global leader — and a trusted partner — with decades of experience in clinical trial technology solutions. From accelerating study start up for trials of all sizes to organizing and distributing all critical training and safety data, Trifecta offers a fully integrated, totally comprehensive platform built from the ground up. And through it, we consistently deliver more trial and less error across an entire portfolio of studies. We are proud to be hosting our annual user group meeting at SCOPE.
Host a User Group on Monday, February 18
Co-locate your User Group meeting with SCOPE Summit. CHI will help market the event & manage logistical operations. We will co-market to prospective attendees and extend your users a discount to attend.